VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $104,658,000 | -46.1% | 586,716 | -32.9% | 3.96% | -23.9% |
| Q2 2015 | $194,223,000 | +1.6% | 874,289 | -9.2% | 5.20% | -11.8% |
| Q1 2015 | $191,216,000 | -2.7% | 962,721 | -29.9% | 5.90% | +8.4% |
| Q4 2014 | $196,551,000 | +9.1% | 1,373,429 | 0.0% | 5.44% | +18.4% |
| Q3 2014 | $180,194,000 | -1.5% | 1,373,429 | -5.3% | 4.60% | -2.5% |
| Q2 2014 | $182,931,000 | +59.0% | 1,450,455 | +66.2% | 4.71% | +48.5% |
| Q1 2014 | $115,035,000 | -29.5% | 872,599 | -37.2% | 3.17% | -30.8% |
| Q4 2013 | $163,063,000 | +37.3% | 1,388,953 | +22.0% | 4.59% | +8.7% |
| Q3 2013 | $118,750,000 | +21.2% | 1,138,220 | 0.0% | 4.22% | +23.4% |
| Q2 2013 | $97,978,000 | – | 1,138,220 | – | 3.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |